Home Publications Research Grants Inventions & Patents Awards Additional Research Activities Faculties & Institutions Research Areas

Kutane's plasma-cell-rich Pseudolymphoma in histologically complete Response under combined Immunotherapy with Talimogene laherparepvec (TVEC) and Pembrolizumab

Erdmann M, Sponagl F, Kiesewetter F, Schliep S (2018)

---

Publication Type: Conference contribution

Publication year: 2018

Journal

Book Volume: 16

Pages Range: 75-75

Authors with CRIS profile

How to cite

APA:

Erdmann, M., Sponagl, F., Kiesewetter, F., & Schliep, S. (2018). Kutane's plasma-cell-rich Pseudolymphoma in histologically complete Response under combined Immunotherapy with Talimogene laherparepvec (TVEC) and Pembrolizumab. (pp. 75-75).

MLA:

Erdmann, M., et al. "Kutane's plasma-cell-rich Pseudolymphoma in histologically complete Response under combined Immunotherapy with Talimogene laherparepvec (TVEC) and Pembrolizumab." 2018. 75-75.

BibTeX: Download